New hires and promotions in the biopharma industry, including: Aavantibio, Arbor.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Antengene, Astrazeneca, Biontech, Cansino, Carsgen, Gannex, GC, Harbour Biomed, Iaso, Idorsia, Innovent, Johnson & Johnson, Pfizer, Qurebio, RDIF, Regeneron, Roche, Sciwind, Very, Wuhan Institute of Biological Products.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Immunoscape, Innocare, Sumitomo Dainippon, Xwpharma.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aivita Biomedical, Altimmune, Ampio, Aslan, Biontech, Chimerix, Constant, Glaxosmithkline, Gtreebnt, I-Mab, Innovation, Innovent Biologics, LG Chem Life Sciences, Neurorx, Novavax, Opthea, Partner, Pfizer, Redhill, Regeneron, Regentree, Revive, Samsung Bioepis, Stero, Takeda, Takis, Theravance, Union.

Quarterly snapshots from biopharma companies with marketed products, including: Amarin, Moderna.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Aslan, Liscure, Medilink.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Allarity, Aridis, Astellas, Beigene, Beijing Tide, Biocardia, Canbridge, Claritas, Daiichi Sankyo, Eli Lilly, ERS Genomics, Essa, FCC Horiuchi, Florica, G+FLAS Life Sciences, Generex, Genscript Probio, Graviton, Hitgen, Insilico Medicine, Moderna, Novartis, Pfizer, Pierre Fabre, Puma, Recce, Sunrock, UCB, Uppthera.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA updates recognized standards list; Advisory hearing scheduled for Transmedics’ OCS; GAO said ‘no’ to Spartan Medical appeal; CDC posts updates on SARS sequencing.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accufix Surgical, Anuncia, Conformis, Fifth Eye, Guardant Health, Masimo, Neurolief.